Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study

NCT01537315 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Kidney Failure, Chronic
Cardiovascular Disease
Arteriosclerosis

Interventions

DRUG: Hydroxychloroquine
OTHER: Matching Placebo

Sponsor

University of Arkansas